Superior vena cava resection in thoracic malignancies: does prosthetic replacement pose a higher risk?
- PMID: 19939694
- DOI: 10.1016/j.ejcts.2009.10.024
Superior vena cava resection in thoracic malignancies: does prosthetic replacement pose a higher risk?
Abstract
Background: After superior vena cava (SVC) resection, the need for reconstruction varies among tangential resection, pericardial patch repair and prosthetic replacement. Patients undergoing complete prosthetic replacement often require a different surgical approach, intra-operative SVC cross-clamping and anticoagulation when polytetrafluoroethylene (PTFE) prosthesis is used. This study tested the hypothesis that PTFE replacement may interfere with perioperative outcome.
Materials and methods: Clinical records from a series of 72 consecutive SVC resections performed between 1998 and 2008 were reviewed. Complications were classed into five categories: surgical, respiratory, cardiac, SVC system thrombosis and nerve damage. Each category of postoperative complications was considered as an outcome variable in a univariate analysis testing 12 covariates as risk factors. Covariates considered clinically relevant or statistically significant were included in the multivariate model.
Results: During the considered period, 28 patients underwent total SVC resection with PTFE prosthetic replacement and 44 patients underwent SVC repair by the use of direct running suture (nine patients), stapling (30 patients) or autologous pericardial patch (five patients). Two patients died postoperatively (2.8%). Major complications were mainly due to respiratory failure, which occurred in nine cases (acute respiratory failure in five cases, recurrent atelectasis in three cases, acute respiratory distress syndrome (ARDS) in one case). In terms of overall mortality and morbidity, univariate analysis did not confirm a detrimental effect of SVC replacement as compared with SVC repair, as major postoperative complications occurred in similar proportion in both groups (respectively, 6/28, 21.4% vs 7/44, 15.9%, p=0.54). No other risk factor was identified by univariate analysis.
Conclusions: Complete prosthetic replacement does not increase overall postoperative morbidity in patients undergoing SVC resection and can be safely performed when other reconstruction techniques preclude sufficient tumour-free resection margin or compromise adequate blood flow.
Copyright (c) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Prosthetic replacement and tangential resection of the superior vena cava in chest tumors.J Cardiovasc Surg (Torino). 2007 Jun;48(3):363-8. J Cardiovasc Surg (Torino). 2007. PMID: 17505442
-
Long-term follow-up after prosthetic replacement of the superior vena cava combined with resection of mediastinal-pulmonary malignant tumors.J Thorac Cardiovasc Surg. 1991 Aug;102(2):259-65. J Thorac Cardiovasc Surg. 1991. PMID: 1865699
-
Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.Ann Thorac Surg. 2007 Jan;83(1):223-9; discussion 229-30. doi: 10.1016/j.athoracsur.2006.07.075. Ann Thorac Surg. 2007. PMID: 17184668
-
[Mediastinal malignant tumor resection and superior vena cava revascularization. Resection of invasive thymoma with growth into the superior vena cava and right atrium using cardiopulmonary bypass].Nihon Kyobu Geka Gakkai Zasshi. 1995 May;43(5):717-9. Nihon Kyobu Geka Gakkai Zasshi. 1995. PMID: 7561298 Review. Japanese. No abstract available.
-
[Surgical vein reconstruction in patients with tumor invasiveness of the superior caval system. Retrospective study of 7 cases].J Chir (Paris). 1996 Apr;133(2):61-4. J Chir (Paris). 1996. PMID: 8763562 Review. French.
Cited by
-
Thoracoscopic thymectomy with partial superior vena cava resection for locally advanced thymomas.J Thorac Dis. 2019 Feb;11(2):438-444. doi: 10.21037/jtd.2018.12.120. J Thorac Dis. 2019. PMID: 30962987 Free PMC article.
-
Is it safe to divide and ligate the left innominate vein in complex cardiothoracic surgeries?Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):560-3. doi: 10.1093/icvts/ivt244. Epub 2013 Jun 4. Interact Cardiovasc Thorac Surg. 2013. PMID: 23736661 Free PMC article. Review.
-
Superior Vena Cava Resection in Locally Advanced Thymoma-Surgical and Survival Outcomes.Indian J Surg Oncol. 2020 Dec;11(4):711-719. doi: 10.1007/s13193-020-01204-5. Epub 2020 Sep 4. Indian J Surg Oncol. 2020. PMID: 33299285 Free PMC article.
-
Thymic en-bloc resection with veins: case demonstrations and review of the literature.Mediastinum. 2024 Jan 8;8:5. doi: 10.21037/med-20-69. eCollection 2024. Mediastinum. 2024. PMID: 38322190 Free PMC article. Review.
-
Patency of grafts after total resection and reconstruction of the superior vena cava for thoracic malignancy.Surg Today. 2016 Dec;46(12):1421-1426. doi: 10.1007/s00595-016-1347-z. Epub 2016 Jun 14. Surg Today. 2016. PMID: 27300545
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical